Abstract. Human leukocyte antigen (HLA) class II molecule is an integral component of the immune response on which the majority of host genetic studies have concentrated. Many different HLA-II alleles have been demonstrated to play roles in HBV infection. PCR-SSOP methods were applied to determine the HLA-DRB1 genotypes of 769 unrelated healthy individuals from Han Chinese of Northeast China. The frequencies of HLA-DRB1 * 09 in hepatitis B virus (HBV)-infected subjects were higher compared to those in the control group. Frequencies of HLA-DRB1 * 04 and * 13 in the HBV-infected group were significantly lower compared to those in the healthy control group. Frequencies of HLA-DRB1 * 12 in the cirrhosis and liver cancer groups were significantly higher than those in the chronic hepatitis B (CHB) patients. The frequency of LA-DRB1 * 03 in the CHB patient group was significantly higher compared to that in the asymptomatic hepatitis B carrier patients. The above results suggest that the host HLA-II gene is an important factor in the determination of the outcome of HBV infection.
Introduction

Hepatitis B virus (HBV) infection is a serious issue.
Approximately two billion people worldwide are infected with HBV (1) . Individuals infected with HBV may be asymptomatic hepatitis B carriers (ASC), but many of these individuals may progressively develop chronic hepatitis B (CHB), liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Susceptibility to HBV infection and the outcome of post-infection vary among individuals; however, the underlying mechanisms are poorly understood (2) (3) (4) . HBV replication in hepatocytes per se does not directly damage the liver, while HBV-induced immune responses may attack HBV-infected hepatocytes, mediating liver damage. Apparently, the status of immunity of an individual is a pivotal determinant for the susceptibility of HBV infection and disease course (3, 4) .
Human leukocyte antigen (HLA) plays an important role in the human immune response by presenting antigens to T cells, regulating T cell immunity. The polymorphism of HLA genes is one of the most important genetic factors in determining the host immune response and is related to the susceptibility of individuals to HBV infection (5, 6) . Previous research has shown that the HLA-I genes are in linkage disequilibrium with CHB and the polymorphisms of HLA-II alleles are associated with susceptibility to CHB (7) . However, the association is racially and geographically dependent (6, (8) (9) (10) .
The prevalence of HBV infection is extremely high in China and many people with HBV infections develop CHB and some progress to the onset of cirrhosis (11) . A follow-up study (1-18.4 years) revealed that 23 and 4.4% of CHB patients with hepatitis B early antigen (HBeAg)-negative serological status progress to the deve lopment of cirrhosis and HCC, respectively (12, 13) . However, there is no information concerning whether the association of HLA with the susceptibility and development of chronic HBV exists in the Han Chinese of Northeast China.
In the present study, we characterized the phenotypes of HLA-DRB1 in subjects with HBV infection and healthy controls, and evaluated the potential association of the HLA-DRB1 polymorphism with HBV susceptibility, ASC, HBV-related CHB, LC and HCC in the Han Chinese of Northeast China. (14), and the diagnoses of the patients with HCC were confirmed by pathological examination. Individuals with a history of familial inherited diseases, immune deficiency, other chronic diseases, such as diabetes, hypertension, multiple sclerosis, rheumatoid arthritis, cardiovascular diseases or with HCV or HDV infection were excluded. The demographic and clinical characteristics of the study subjects are presented in Table I . Written informed consent was obtained from all individuals and the experimental protocol was approved by the Ethics Committee of the First Hospital of Jilin University.
Materials and methods
Subjects
DNA extraction and HLA-DRB1 * genotyping. Blood samples (approximately 2 ml) were collected from individual participants and genomic DNA was extracted using the DNA extraction kit, according to the manufacturer's instructions (Invitrogen). After qualification and quantification of the isolated DNA with ratios of A230/280 at 1.65-1.90, the DNA samples were adjusted to ≥50 ng/µl. The genotypes of individual DNA samples were characterized by the PCR-SSOP typing analysis using the HLA-DRB1 genotyping kit, according to the manufacturer's instructions (DYNAL). Briefly, the second exon of the HLA-DRB1 gene was amplified by PCR using previously reported primers (15) . The PCR reactions in duplicate were performed at 95˚C for 5 min and subjected to 34 cycles of 95˚C for 20 sec, 64˚C for 20 sec and 72˚C for 45 sec, followed by extension at 72˚C for 5 min. The biotinylated PCR products were subsequently characterized by 2% agarose gel electrophoresis and visualized under UV exposure. The expected size of the product was approximately 270 bp.
Subsequently, the amplified DNA was denatured and hybridized with complementary DNA probes coupled to microbeads. After washing, the microbeads were probed with phycoerythrin (PE)-conjugated streptavidin at room temperature for 1 h. The fluorescent intensity of the biotiny lated PCR product on each coded oligobead was measured using a Luminex-200 apparatus. The HLA-DRB1 * genotype of individual samples was determined using the Genosearch Typing software-Luminex 100 IS (version 2.3), and the HLA typing of individuals was analyzed using the Dynal AccuPlex software.
Serological tests. Serological analyses of HBV, HCV and HDV infection and the concentrations of serum HBV DNA were analyzed using enzyme-linked immunosorbent assay (ELISA) and fluorescence quantitative PCR, respectively, by the Testing Center of the First Affiliated Hospital, Jilin University. A cut-off value of ≤10 5 copies/ml was regarded as negative. Liver function tests were analyzed using a Beckman Coulter LX20 analyzer by the Testing Center of the First Affiliated Hospital, Jilin University.
Statistical assay. Allele frequencies were calculated using the direct counting method. The differences in allele frequencies among groups were analyzed using the χ 2 test and Fisher's exact test, and the association of allele genotypes with the disease was estimated by the odds risk (OR) and 95% confidence interval (CI) using statistical software SPSS 17.0. P<0.05 was considered to indicate a statistically significant difference and was further corrected by the Bonferroni correction (Pc).
Results
Frequencies of the HLA-DRB1 alleles. The frequencies of HLA-DRB1 alleles between the 396 HBV-infected patients and 400 control subjects were compared (Table II) Association of HLA-DRB1 alleles with CHB and ASC. The frequencies of HLA-DRB1 alleles and their relative risk for ASC and CHB were further analyzed (Table III) . The frequency of HLA-DRB1 * 03 (8.75%) in the CHB patients was significantly higher than the frequency (3.45%) in the ASC group (P<0.05, OR=0.372). However, there was no significant difference in the distribution of other HLA-DRB1 alleles between patients and controls in this population.
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Association of HLA-DRB1 alleles with CHB, LC and HCC.
The frequencies of the HLA-DRB1 alleles and their relative risk for CHB, HBV-related liver cirrhosis and HCC were analyzed (Table IV) . The frequencies of HLA-DRB1 * 12 in the patients with HBV-related liver cirrhosis (15.05%) and HCC (18.02%) were significantly higher than the frequency (8.33%) in the CHB patients (P<0.05, OR=1.949 and P<0.05, OR=2.418, respectively). However, there was no significant difference in the frequencies of HLA-DRB1 alleles between the patients with HBV-related liver cirrhosis and the patients with HCC (P>0.05).
Discussion
The HLA genotype has been thought to be a genetic factor for the prediction of the susceptibility of individuals to HBV infection and prognosis of the disease in certain populations (3, 4) . The association of HLA alleles with the susceptibility of individuals to HBV infection and disease progression varies since multiple factors, such as geography and ethnicity, affect this association (6, (8) (9) (10) . To investigate the association of the frequency of HLA-DRB1 alleles with the susceptibility of individuals to HBV infection in the Han Chinese of Northeast China, we characterized the genotypes of 396 patients with ASC, CHB, HBV-related liver cirrhosis or HCC and 400 healthy subjects. We found that the frequency of HLA-DRB1 * 09 in the HBV-infected patients was significantly higher than that in the healthy controls, suggesting that the HLA-DRB1 * 09 alleles are associated with increased risk for the infection and progression of HBV and CHB in the Han Chinese of Northeast China. The results are consistent with a previous report (16) , which showed a significantly higher frequency of HLA-DRB1 * 09 in CHB patients. To investigate the potential association of HLA-DRB1 genotypes and persistent infection of HBV in this population, we compared the frequencies of HLA-DRB1 alleles between Table III . Distribution of the HLA-DRB1 alleles in the ASC and CHB groups. the HBV-infected patients and healthy controls. We found that the HLA-DRB1 * 03 allele was more frequent in the HBV higher load group than in the ASC lower replication group, suggesting that HLA-DRB1 * 03 may be associated with persistent infection of the hepatitis B virus (17, 18) . We also found that the frequencies of the HLA-DRB1 * 04 and * 13 alleles in the HBV-infected patients were significantly lower than those in healthy controls, suggesting that these alleles may be associated with a reduced risk for the development of CHB even after infection with HBV. Our results agree with previous findings that the HLA-DRB1 * 04/ * 06, HLA-DRB1 * 11/ * 12, HLA-DRB1 * 1101/ * 1104 are associated with the clearance of HBV (16, (19) (20) (21) . Association of the HLA-DRB1 * 13 with viral clearance is well established (22, 23 (20) . Notably, the frequency of the HLA-DRB1 * 13 allele in Asians is much lower than that in Caucasians, which may contribute to the high prevalence of HBV infection in Asians. We are interested in further investigating the mechanisms by which the HLA-DRB1 * 04 and * 13 alleles reduce the susceptibility of the Han Chinese to HBV infection.
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Analysis of the potential association of HLA-DRB1 alleles with the progression of CHB revealed that the frequency of the HLA-DRB1 * 12 allele in HBV-related liver cirrhosis and patients with HCC was significantly higher than that in CHB patients, suggesting that the allele could be a candidate genetic factor for the progression of CHB into liver cirrhosis and HCC.
Our results were consistent with a previous report that the HLA-DRBl * 1201/ * 1202 allele is associated with an increased risk for the development of HBV-related liver cirrhosis, and the HLA-DRBl * 04 allele for the development of HCC (24) (25) (26) . The inconsistent association of HLA-DRBl alleles with the progression of HBV infection in different regions of the Han Chinese may be attributed to varying geographical and environmental factors. We recognized our study in a relatively small population, and many data categories were based on a few cases. Thus, a nationwide collaborative study with a large population is warranted to clarify the association of HLA-DRBl alleles with the susceptibility of the Han Chinese to HBV infection and the progression of CHB into liver cirrhosis and HCC.
In conclusion, our results show that, HLA-DRBl typing, to a certain extent, is associated with the persistence of HBV, and the HLA genotype may have an impact on the prognosis of HBV infection. To identify the alleles that specifically affect the susceptibility to chronic HBV infection, further investigation should include a larger sample size, with extended analysis of the low-frequency gene locus in the Chinese population, developing the family pedigree of CHB and the linkage disequilibrium analysis. Table IV . Distribution of HLA-DRB1 alleles in the CHB, LC and HCC groups. 
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